15,083 Shares in Danaher Corporation $DHR Purchased by B & T Capital Management DBA Alpha Capital Management

Key Points

• B & T Capital Management acquired 15,083 Danaher shares worth approximately $10.86 million, making up 1.4% of its portfolio. Institutional investors collectively own 79.05% of Danaher.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $228.91, although several firms recently lowered their targets.
• Danaher exceeded quarterly expectations, reporting $1.94 in EPS versus $1.85 forecast and $6.26 billion in revenue versus $6.12 billion expected. Revenue increased 5.5% year over year.

B & T Capital Management DBA Alpha Capital Management acquired a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 15,083 shares of the conglomerate's stock, valued at approximately $10,860,000. Danaher makes up approximately 1.4% of B & T Capital Management DBA Alpha Capital Management's holdings, making the stock its 17th largest position.

Several other hedge funds have also recently bought and sold shares of the company. BlackRock Inc. bought a new stake in shares of Danaher during the 2nd quarter worth approximately $10,492,520,000. Norges Bank acquired a new stake in shares of Danaher during the 4th quarter worth approximately $2,177,106,000. Bank of New York Mellon Corp bought a new position in Danaher in the second quarter valued at approximately $712,875,000. Viking Global Investors LP raised its position in Danaher by 543.9% during the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate's stock valued at $574,351,000 after purchasing an additional 2,455,994 shares in the last quarter. Finally, Deutsche Bank AG acquired a new position in Danaher during the second quarter valued at approximately $446,265,000. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. TD Cowen reduced their target price on Danaher from $240.00 to $236.00 and set a "buy" rating on the stock in a report on Wednesday, July 22nd. Piper Sandler began coverage on Danaher in a report on Thursday, June 11th. They set a "neutral" rating and a $200.00 price target for the company. Wall Street Zen downgraded Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, April 25th. Stifel Nicolaus reduced their price objective on Danaher from $260.00 to $220.00 and set a "buy" rating on the stock in a research note on Wednesday, July 22nd. Finally, HSBC decreased their target price on Danaher from $270.00 to $230.00 and set a "buy" rating on the stock in a research report on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $228.91.

Danaher Trading Down 0.0%

NYSE DHR opened at $202.44 on Tuesday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a market cap of $142.31 billion, a price-to-earnings ratio of 35.96, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78. The business's fifty day moving average is $193.52 and its 200 day moving average is $192.67.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business's revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.77 EPS. As a group, sell-side analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source